BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 27774846)

  • 1. MLL-rearranged mixed phenotype acute leukemia masquerading as B-cell ALL.
    Yang W; Tran P; Khan Z; Rezk S; O'Brien S
    Leuk Lymphoma; 2017 Jun; 58(6):1498-1501. PubMed ID: 27774846
    [No Abstract]   [Full Text] [Related]  

  • 2. Blinatumomab for paediatric mixed phenotype acute leukaemia.
    Bartram J; Balasch-Carulla M; Bhojaraja S; Adams S; Cheng D; Inglott S; Kulkarni N; Mahendrayogam A; O'Connor O; Pavasovic V; Vora A
    Br J Haematol; 2021 Oct; 195(2):289-292. PubMed ID: 34254287
    [No Abstract]   [Full Text] [Related]  

  • 3. Mixed-Phenotype Acute Leukemia: Diagnostic Criteria and Pitfalls.
    Charles NJ; Boyer DF
    Arch Pathol Lab Med; 2017 Nov; 141(11):1462-1468. PubMed ID: 29072953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent antileukemic activity of curaxin CBL0137 against MLL-rearranged leukemia.
    Somers K; Kosciolek A; Bongers A; El-Ayoubi A; Karsa M; Mayoh C; Wadham C; Middlemiss S; Neznanov N; Kees UR; Lock RB; Gudkov A; Sutton R; Gurova K; Haber M; Norris MD; Henderson MJ
    Int J Cancer; 2020 Apr; 146(7):1902-1916. PubMed ID: 31325323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggressive MLL gene rearranged CD7+ CD56+ myeloid / natural killer cell precursor acute leukaemia with extramedullary relapse in the uterus and breast.
    Soon G; Lee SY; Wang S
    Pathology; 2015 Oct; 47(6):588-91. PubMed ID: 26308138
    [No Abstract]   [Full Text] [Related]  

  • 6. Two consecutive immunophenotypic switches in a child with MLL-rearranged acute lymphoblastic leukemia.
    Germano G; Pigazzi M; del Giudice L; Campo Dell'Orto M; Spinelli M; Zangrando A; Paolucci P; Ladogana S; Basso G
    Haematologica; 2006 May; 91(5 Suppl):ECR09. PubMed ID: 16709517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy.
    Gardner R; Wu D; Cherian S; Fang M; Hanafi LA; Finney O; Smithers H; Jensen MC; Riddell SR; Maloney DG; Turtle CJ
    Blood; 2016 May; 127(20):2406-10. PubMed ID: 26907630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixed lineage rearranged leukaemia: pathogenesis and targeting DOT1L.
    Stein EM; Tallman MS
    Curr Opin Hematol; 2015 Mar; 22(2):92-6. PubMed ID: 25635757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infantile mixed phenotype acute leukemia (bilineal and biphenotypic) with t(10;11)(p12;q23);MLL-MLLT10.
    Lou Z; Zhang CC; Tirado CA; Slone T; Zheng J; Zaremba CM; Oliver D; Chen W
    Leuk Res; 2010 Aug; 34(8):1107-9. PubMed ID: 20299091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-cell acute lymphoblastic leukemia with mature phenotype and MLL rearrangement: report of five new cases and review of the literature.
    Sajaroff EO; Mansini A; Rubio P; Alonso CN; Gallego MS; Coccé MC; Eandi-Eberle S; Bernasconi AR; Ampatzidou M; Paterakis G; Papadhimitriou SI; Petrikkos L; Papadakis V; Polychronopoulou S; Rossi JG; Felice MS
    Leuk Lymphoma; 2016 Oct; 57(10):2289-97. PubMed ID: 26857438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unusual profiles of pediatric acute lymphoblastic leukemia with MLL gene rearrangement.
    Kubicka M; Soszynska K; Mucha B; Rafinska B; Kolodziej B; Haus O; Styczynski J
    Leuk Lymphoma; 2007 Oct; 48(10):2083-6. PubMed ID: 17917979
    [No Abstract]   [Full Text] [Related]  

  • 12. Flow cytometric predictive scoring systems for common fusions ETV6/RUNX1, BCR/ABL1, TCF3/PBX1 and rearrangements of the KMT2A gene, proposed for the initial cytogenetic approach in cases of B-acute lymphoblastic leukemia.
    Tsagarakis NJ; Papadhimitriou SI; Pavlidis D; Marinakis T; Kostopoulos IV; Stiakaki E; Polychronopoulou S; Paterakis G
    Int J Lab Hematol; 2019 Jun; 41(3):364-372. PubMed ID: 30730614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pediatric B lineage leukemia with coincident MYC and MLL translocations.
    Meeker ND; Cherry AM; Bangs CD; Frazer JK
    J Pediatr Hematol Oncol; 2011 Mar; 33(2):158-60. PubMed ID: 20829716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique Familial MLL(KMT2A)-Rearranged Precursor B-Cell Infant Acute Lymphoblastic Leukemia in Non-twin Siblings.
    Urtishak KA; Robinson BW; Rappaport EF; Sarezky MD; Biegel JA; Nichols KE; Wilmoth DM; Wang LS; Stern JW; Felix CA
    Pediatr Blood Cancer; 2016 Jul; 63(7):1175-80. PubMed ID: 26999444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lineage classification of childhood acute lymphoblastic leukemia according to the EGIL recommendations: results of the ALL-BFM 2000 trial.
    Ratei R; Schabath R; Karawajew L; Zimmermann M; Möricke A; Schrappe M; Ludwig WD
    Klin Padiatr; 2013 May; 225 Suppl 1():S34-9. PubMed ID: 23700065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MLL-ENL-mediated leukemia initiation at the interface of lymphoid commitment.
    Ugale A; Säwén P; Dudenhöffer-Pfeifer M; Wahlestedt M; Norddahl GL; Bryder D
    Oncogene; 2017 Jun; 36(22):3207-3212. PubMed ID: 28068328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent genetic fusions redefine MLL germ line acute lymphoblastic leukemia in infants.
    Fazio G; Bardini M; De Lorenzo P; Grioni A; Quadri M; Pedace L; Corral Abascal L; Palamini S; Palmi C; Buldini B; Vinti L; Parasole R; Barisone E; Zecca M; Favre C; Locatelli F; Conter V; Rizzari C; Valsecchi MG; Biondi A; Cazzaniga G
    Blood; 2021 Apr; 137(14):1980-1984. PubMed ID: 33512459
    [No Abstract]   [Full Text] [Related]  

  • 18. Frequency and prognostic significance of t(v;11q23)/KMT2A rearrangements in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols.
    Motlló C; Ribera JM; Morgades M; Granada I; Montesinos P; Brunet S; Bergua J; Tormo M; García-Boyero R; Sarrà J; Del Potro E; Grande C; Barba P; Bernal T; Amigo ML; Grau J; Cervera J; Feliu E;
    Leuk Lymphoma; 2017 Jan; 58(1):145-152. PubMed ID: 27122129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent detection of a novel MLL-SACM1L rearrangement in the absence of leukemia.
    Mori T; Nishimura N; Hasegawa D; Kawasaki K; Kosaka Y; Uchide K; Yanai T; Hayakawa A; Takeshima Y; Nishio H; Matsuo M
    Leuk Res; 2010 Oct; 34(10):1398-401. PubMed ID: 20553989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-150:targeting MLL leukemia.
    Jiang X; Chen J
    Oncotarget; 2012 Nov; 3(11):1268-9. PubMed ID: 23175472
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.